S122: safety and efficacy of crizanlizumab in adolescents with sickle cell disease (scd): initial data from the phase ii, multicenter, open-label solace-kids trialM Heeney,D Rees,M de Montalembert, I Odame, C Brown,Y Wali,T Nguyen, D Lam, N Pfender,J KanterHemaSphere（2022）引用 2|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
